GlassScriptPhysician profile
Michael Padilla
NPI 1043416787
$27,101.86
in general payments reported to CMS, 2019-2025
23 companies · $4,078 in 2025
The $4,078 reported for 2025 was more than what 80% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,248 · 2020: $1,443 · 2021: $4,946 · 2022: $4,341 · 2023: $4,510 · 2024: $4,537 · 2025: $4,078.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Travel and Lodging: $2,627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,497.25 |
| Travel and Lodging | $2,627.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $9,158.44 | 2020-2025 | Inspace, Mistral-Air, Iconix |
| Arthrex, INC. | $8,116.34 | 2019-2024 | |
| Pylant Medical | $5,114.84 | 2019-2025 | |
| Anika Therapeutics, INC. | $1,058.14 | 2021-2024 | Revomotion, Integrity, Tactoset |
| Miach Orthopaedics, INC. | $978.13 | 2023-2025 | |
| Depuy Synthes Sales INC. | $872.85 | 2020-2025 | Tfn-Advance, Dynaforce, Fibergraft Aeridyan Matrix |
| Smith+Nephew, INC. | $734.43 | 2021-2025 | Bone Anchors With Arthroscopic Delivery System |
| Organogenesis INC. | $268.52 | 2021-2023 | Puraply |
| Inari Medical, INC. | $154.68 | 2021 | |
| Abbvie INC. | $132.76 | 2021-2024 | |
| Pacira Pharmaceuticals Incorporated | $112.62 | 2024 | Iovera |
| Zimmer Biomet Holdings, INC. | $104.11 | 2025 | Gel-One Cross-Linked Hyaluronate |
| Innovation Technologies INC | $68.00 | 2023 | Irrisept |
| Boston Scientific Corporation | $51.46 | 2024 | |
| Ethicon US, LLC | $34.31 | 2024 | Stratafix, Vistaseal |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trice Medical, INC. | $29.46 | 2020 | |
| Abbott Laboratories | $29.03 | 2021 | |
| Horizon Therapeutics Plc | $22.01 | 2023 | Krystexxa |
| Vericel Corporation | $16.50 | 2021 | |
| Bioventus LLC | $14.61 | 2023 | Exogen Ultrasound Bone Healing System |
| Amgen INC. | $13.79 | 2023 | Evenity, Prolia |
| Medtronic, INC. | $13.19 | 2022 | |
| Skeletal Dynamics INC | $3.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Padilla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.